OTCMKTS:SPHRY

Starpharma - SPHRY Stock Forecast, Price & News

$3.80

0.00 (0.00%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $3.80
▼
$3.80
50-Day Range: $3.76
▼
$5.65
52-Week Range: $3.76
▼
$9.50

Volume: 300 shs
Average Volume: 2,484 shs
Market Capitalization: $155.19 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Starpharma (OTCMKTS:SPHRY) Stock

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, it develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase 2 clinical trials, DEP cabazitaxel that is in Phase 2 clinical trial, DEP gemcitabine that is in a Phase 1/2 clinical trials, and DEP irinotecan that is in Phase 2 clinical trials for the treatment of cancer; DEP radiotheranostics for cancer treatment and diagnosis; DEP Antibody Drug Conjugates; DEP HER-2 ADC; DEP non-oncology candidates; and DEP AZD0466, which is in Phase 1/2 clinical trials to treat haematological malignancies. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

Receive SPHRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter.

SPHRY Stock News Headlines

September 12, 2022 | finance.yahoo.com

Starpharma presents compelling data in Prostate Cancer at ESMO

August 10, 2022 | finance.yahoo.com

Starpharma signs new DEP® agreement with MSD

July 20, 2022 | finanznachrichten.de

Starpharma: VIRALEZE Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral Exposure

January 12, 2022 | nasdaq.com

Starpharma Holdings Ltd. ADR (SPHRY)

December 13, 2021 | msn.com

What is happening to the Starpharma (ASX:SPL) share price today?

December 6, 2021 | msn.com

Starpharma (ASX:SPL) share price shoots 6% higher on Roche agreement

November 19, 2021 | msn.com

Why is the Starpharma (ASX:SPL) share price trading at 52-week lows?

October 28, 2021 | markets.businessinsider.com

Perth businesswoman Kim Tran launches new business, scores supply deal with Starpharma

October 26, 2021 | msn.com

Starpharma (ASX:SPL) share price lifts on supply and distribution deal

October 8, 2021 | finance.yahoo.com

VIRALEZE™ antiviral nasal spray launched in ADMENTA Italia Group pharmacies in Italy

September 15, 2021 | finance.yahoo.com

US Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma's phase 2 clinical-stage cancer treatments

August 26, 2021 | msn.com

Starpharma (ASX:SPL) share price tanks 3% on 67% revenue drop

July 26, 2021 | msn.com

Why the Starpharma (ASX:SPL) share price is racing 7% higher today

June 24, 2021 | finance.yahoo.com

Starpharma to Webcast Live at Life Sciences Investor Forum June 24th

June 21, 2021 | msn.com

Why the Starpharma (ASX:SPL) share price is down 10% today

June 11, 2021 | msn.com

Starpharma (ASX:SPL) share price rebounds after receiving Indian approval for COVID-19 product

June 11, 2021 | finance.yahoo.com

Viraleze registered for sale in Covid-ravaged India

May 11, 2021 | msn.com

Starpharma (ASX:SPL) share price slides despite COVID spray rugby deal

May 5, 2021 | msn.com

Starpharma (ASX:SPL) share price surges higher on COVID product update

April 26, 2021 | msn.com

Starpharma (ASX:SPL) share price edges higher on update

April 13, 2021 | msn.com

Why the Starpharma (ASX:SPL) share price is up 27% in 2021

March 25, 2021 | msn.com

Starpharma (ASX:SPL) share price pushes higher on COVID-19 nasal spray update

February 27, 2021 | seekingalpha.com

Starpharma Up With News, Down With None; Timing Entry Makes Sense

February 11, 2021 | msn.com

Here’s why the Starpharma (ASX:SPL) share price just stormed to a record high

February 8, 2021 | msn.com

Why the Starpharma (ASX:SPL) share price hit a record high today

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SPHRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter.

SPHRY Company Calendar

Today: 10/02/2022
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:SPHRY
CUSIP: N/A
CIK: N/A
Web: www.starpharma.com
Phone: (138) 532-2700
Fax: 61-3-9510-5955
Employees: 50
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 7.01
Quick Ratio: 6.80

Sales & Book Value

Annual Sales: $1.61 million
Price / Sales: 96.39
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.15 per share
Price / Book: 3.30

Miscellaneous

Outstanding Shares: 40,840,000
Free Float: N/A
Market Cap: $155.19 million
Optionable: Not Optionable
Beta: 1.55

Key Executives

Dr. Jacinth K. Fairley B.Sc. (Age 59)
B.V.Sc.(Hons), MBA, GAICD, CEO, MD & Exec. Director
Comp: $520.77k

Mr. Nigel J. Baade B.Com
Grad. Dip., CPA, CFO & Company Sec.

Key Competitors

View All Competitors

SPHRY Stock - Frequently Asked Questions

How have SPHRY shares performed in 2022?: Starpharma's stock was trading at $9.50 at the beginning of 2022. Since then, SPHRY shares have decreased by 60.0% and is now trading at $3.80.
View the best growth stocks for 2022 here.
What is Starpharma's stock symbol?: Starpharma trades on the OTCMKTS under the ticker symbol "SPHRY."

How do I buy shares of Starpharma?: Shares of SPHRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Starpharma's stock price today?: One share of SPHRY stock can currently be purchased for approximately $3.80.
How much money does Starpharma make?: Starpharma (OTCMKTS:SPHRY) has a market capitalization of $155.19 million and generates $1.61 million in revenue each year.
How can I contact Starpharma?: Starpharma's mailing address is 4-6 Southampton Crescent, Abbotsford C3, 3072. The official website for the company is www.starpharma.com. The company can be reached via phone at (138) 532-2700, via email at investor.relations@starpharma.com, or via fax at 61-3-9510-5955.

This page (OTCMKTS:SPHRY) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms